Surgical Management of Cardiovascular Lesions Caused By Systemic Inflammatory Diseases

Moro, H; Hayashi, J; Ohzeki, Hajime; Sogawa, Masakazu; Nakayama, Takayuki; Namura, Osamu

doi:10.1055/s-2007-1013120

Cited by 16 publications

(9 citation statements)

References 0 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Aspirin may contribute to a decrease in the the inflammatory process as well. • When cardiovascular surgery is necessary, it is crucial to keep in mind the need to reduce inflammation pre-and postoperatively, to reinforce suture lines, and to select operative procedures accordingly [79].…”

Section: Treatmentmentioning

confidence: 99%

Cardiovascular complications of collagen vascular disease

Sander

Giles

2002

Curr Treat Options Cardio Med

View full text Add to dashboard Cite

Collagen vascular diseases commonly affect the heart; cardiovascular events are the major cause of mortality in people with these diseases. A striking feature of the cardiac involvement in individuals with systemic lupus erythematosus (SLE) and rheumatoid arthritis is aggressive and accelerated atherosclerosis; women with SLE in the 35- to 44-year-old age group are more than 50 times more likely to suffer myocardial infarction than are matched controls. Traditional risk factors contribute to the accelerated atherosclerosis, but cannot explain the extent of risk. It is possible that the inflammatory process, which is similar to the inflammatory process in atherosclerosis, pays a critical pathophysiologic role. It is critically important to identify the presence of traditional cardiovascular risk factors (eg, tobacco usage, hypertension, hypercholesterolemia, diabetes, homocysteinemia), and to modify these to secondary prevention targets. Cardiac valvular disease is common in individuals with SLE and rheumatoid arthritis; its presence should be anticipated and subacute bacterial endocarditis prophylaxis precautions initiated. Cardiac autonomic neuropathy and conduction disturbances are common in people with heart disease related to systemic sclerosis and human leukocyte antigen B27; these patients should be monitored carefully for evidence of dysrhythmias.

show abstract

Section: Treatmentmentioning

confidence: 99%

Cardiovascular complications of collagen vascular disease

Sander

Giles

2002

Curr Treat Options Cardio Med

View full text Add to dashboard Cite

show abstract

“…9 Thus it is crucial to reduce inflammation preoperatively and postoperatively, to reinforce the suture line, and carefully select the operative procedure for treatment of cardiovascular disorders caused by systemic inflammatory diseases. 10 In a study by Stamp and colleagues 7 of a patient with HLA-B27-associated spondyloarthropathy and severe ascending aortitis, sulfasalazine, prednisolone, cyclophosphamide, or azathioprine treatment was administered preoperatively because of extensive systemic inflammation and rapid expansion of the ascending aortic aneurysm. They focused on reducing potential postoperative complications.…”

Section: Discussionmentioning

confidence: 99%

Recurrent giant sinus of Valsalva aneurysm and ankylosing spondylitis

Ercan

Cakici

Davutoğlu

et al. 2013

Asian Cardiovasc Thorac Ann

View full text Add to dashboard Cite

A 48-year-old woman underwent aneurysmectomy and primary suture repair with a pericardial patch for sinus of Valsalva aneurysm secondary to ankylosing spondylitis. The sinus of Valsalva aneurysm recurred one year after surgery, and reached a diameter of 53 mm. Special attention must be paid to the potential relapse of aortic aneurysms that develop secondary to autoimmune disorders, when using primary suture or patch repair.

show abstract

“…Previous studies have shown the increased risk of surgical procedures during active disease [1,22,24,27] but Miyata and colleagues showed that systemic inflammation and steroid administration had little influence on formation of anastomotic aneurysm [23]. Instead, anastomotic aneurysm tended to occur after operations for aneurismal lesions.…”

Section: Discussionmentioning

confidence: 99%

Treatment of takayasu arteritis in the chronic stages: An analysis of 14 operated patients

et al. 2011

View full text Add to dashboard Cite

The aim of this study was to evaluate clinical features, angiographic findings, surgical treatment, and the long-term results of surgical procedures in chronic phase of Takayasu Arteritis. Between 1989 and December 2000, 14 young female patients (mean age, 31 years) with occlusive lesions caused by Takayasu Arteritis were observed and treated at our department. All patients met the American College of Rheumatology 1990 criteria of classification of Takayasu Arteritis. Systemic symptoms were reported in fewer than 15%. All patients were evaluated by a routine full aortography. Occlusive disease was dominant (92.8%) and the subclavian and carotid arteries were mostly involved. All our patients underwent surgery and 30 vascular procedures were done. Polytetrafluoroehylene was the most common synthetic graft. The ipsilateral carotid artery was the most common proximal anastomotic site and the ascending aorta was used twice. Follow-up ranged from 1 to 9 years (mean 6 years) and there was no death. All patients had serial duplex and 6 at least one postoperative angiogram. Twenty percent of the bypass procedures were followed by complications. There was no difference between the complication rate using synthetic grafts or autologous veins. The actuarial graft patency rate was 96.4% at one year and 72% at 4 years. At side of the medical treatment which remains, to date, a subject of discussion, the long-term prognosis of Takayasu Arteritis depends on an elective surgical treatment, which requires full and accurate assessment of the lesions, best done by digital full arteriography. Surgical results are excellent with minimal morbidity and mortality.

show abstract

Surgical Management of Cardiovascular Lesions Caused By Systemic Inflammatory Diseases

Cited by 16 publications

References 0 publications

Cardiovascular complications of collagen vascular disease

Cardiovascular complications of collagen vascular disease

Recurrent giant sinus of Valsalva aneurysm and ankylosing spondylitis

Treatment of takayasu arteritis in the chronic stages: An analysis of 14 operated patients

Contact Info

Product

Resources

About